{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:44:41Z","timestamp":1793159081180,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108899","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T15:51:39Z","timestamp":1755877899000},"page":"108899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidine derivatives as new antiproliferative agents with multikinase inhibitory activity"],"prefix":"10.1016","volume":"165","author":[{"given":"Assem H.","family":"Eldeeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai I.","family":"Shahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiy Y.","family":"Jaballah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R.","family":"Elaraby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamer M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud M.","family":"Elaasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deena S.","family":"Lasheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalal A.","family":"Abou El Ella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2025.108899_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108899_bb0010","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108899_bb0015","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.3390\/ijms18122543","article-title":"Protein kinase targets in breast Cancer","volume":"18","author":"Garc\u00eda-Aranda","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108899_bb0020","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","article-title":"Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics","volume":"10","author":"Anand","year":"2022","journal-title":"Genes & Diseases"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108899_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.175","article-title":"Role of protein phosphorylation in cell signaling, disease, and the intervention therapy","volume":"3","author":"Pang","year":"2022","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-018-0804-2","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","volume":"17","author":"Bhullar","year":"2018","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0035","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-024-01899-w","article-title":"Therapeutic advances of targeting receptor tyrosine kinases in cancer","volume":"9","author":"Tomuleasa","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0040","first-page":"43","article-title":"Tropomyosin-receptor-kinases signaling in the nervous system","volume":"8","author":"Stoleru","year":"2013","journal-title":"Maedica"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0045","first-page":"37","article-title":"Nerve growth factor & TrkA as novel therapeutic targets in cancer","volume":"1866","author":"Demir","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108899_bb0050","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"18","key":"10.1016\/j.bioorg.2025.108899_bb0055","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/onc.2009.61","article-title":"TrkA overexpression enhances growth and metastasis of breast cancer cells","volume":"28","author":"Lagadec","year":"2009","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108899_bb0060","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.3390\/ph17121667","article-title":"Design, synthesis and molecular Modeling of pyrazolo[1,5-a]pyrimidine derivatives as dual inhibitors of CDK2 and TRKA kinases with antiproliferative activity","volume":"17","author":"Attia","year":"2024","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108899_bb0065","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.3390\/ijms22062935","article-title":"Cyclin-dependent kinases (CDK) and their role in diseases development-review","volume":"22","author":"\u0141ukasik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108899_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11912-021-01038-6","article-title":"Emerging therapeutics for patients with triple-negative breast Cancer","volume":"23","author":"Agostinetto","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.bioorg.2025.108899_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175586","article-title":"The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF","volume":"949","author":"Ghalehbandi","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0080","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.108899_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105336","article-title":"Design and synthesis of novel furan, furo[2,3-d]pyrimidine and furo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as potential VEGFR-2 inhibitors","volume":"116","author":"Abd El-Mageed","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108899_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation Signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108899_bb0095","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejps.2014.04.011","article-title":"Identification of new 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines as highly potent EGFR-TK inhibitors with Src-family activity","volume":"59","author":"Kaspersen","year":"2014","journal-title":"European J. Pharmaceutical Sci: Official J. European Federation Pharmaceutical Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108899_bb0100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/cancers13051027","article-title":"A novel bispecific antibody targeting EGFR and VEGFR2 is effective against triple negative breast Cancer via multiple mechanisms of action","volume":"13","author":"Mohan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.108899_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2022.100358","article-title":"Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy","volume":"16","author":"Xu","year":"2022","journal-title":"Materials Today. Bio."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108899_bb0110","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3390\/ph16091324","article-title":"Discovery of new Pyrrolo[2,3-d]pyrimidine derivatives as potential multi-targeted kinase inhibitors and apoptosis inducers","volume":"16","author":"Alotaibi","year":"2023","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2025.108899_bb0115","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3389\/fchem.2019.00917","article-title":"Novel anticancer fused pyrazole derivatives as EGFR and VEGFR-2 dual TK inhibitors","volume":"7","author":"Saleh","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.108899_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113389","article-title":"Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors","volume":"218","author":"Hassan","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"7\u20138","key":"10.1016\/j.bioorg.2025.108899_bb0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/13543776.2023.2262136","article-title":"Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update","volume":"33","author":"Jaworski","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2025.108899_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115101","article-title":"Triazole-fused pyrimidines in target-based anticancer drug discovery","volume":"249","author":"Dai","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108899_bb0135","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ejmech.2018.07.024","article-title":"Synthesis, anticancer activity and molecular modeling studies of 1,2,4-triazole derivatives as EGFR inhibitors","volume":"156","author":"El-Sherief","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108899_bb0140","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/cmdc.201100304","article-title":"N-[2-Methyl-5-(triazol-1-yl)phenyl]pyrimidin-2-amine as a scaffold for the synthesis of inhibitors of Bcr-Abl","volume":"6","author":"Arioli","year":"2011","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/ardp.200900082","article-title":"Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety","volume":"343","author":"Abdel-Aziz","year":"2010","journal-title":"Arch. Pharm."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108899_bb0150","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1021\/jm049597+","article-title":"A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor","volume":"48","author":"Chang","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108899_bb0155","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/jhet.5570420612","article-title":"The reaction of amino-imidazoles, \u2212pyrazoles and -triazoles with \u03b1,\u03b2-unsaturated nitriles","volume":"42","author":"Komykhov","year":"2005","journal-title":"J. Heterocyclic Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108899_bb0160","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1158\/1535-7163.MCT-21-0632","article-title":"Molecular characteristics of Repotrectinib that enable potent inhibition of TRK fusion proteins and resistant mutations","volume":"20","author":"Murray","year":"2021","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0165","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1038\/s41467-023-38732-x","article-title":"Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding","volume":"14","author":"Faber","year":"2023","journal-title":"Nat. Commun."},{"issue":"45","key":"10.1016\/j.bioorg.2025.108899_bb0170","doi-asserted-by":"crossref","first-page":"18281","DOI":"10.1073\/pnas.1207759109","article-title":"Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors","volume":"109","author":"McTigue","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2025.108899_bb0175","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/nature08622","article-title":"Novel mutant-selective EGFR kinase inhibitors against EGFR T790M","volume":"462","author":"Zhou","year":"2009","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.bioorg.2025.108899_bb0180","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.tetlet.2009.02.172","article-title":"An aqueous medium synthesis and tautomerism study of 3(5)-amino-1,2,4-triazoles","volume":"50","author":"Dolzhenko","year":"2009","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2025.108899_bb0185","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ejmech.2013.06.051","article-title":"A structure-activity relationship study of 1,2,4-triazolo[1,5-a][1,3,5]triazin-5,7-dione and its 5-thioxo analogues on anti-thymidine phosphorylase and associated anti-angiogenic activities","volume":"67","author":"Bera","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108899_bb0190","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/jm9507993","article-title":"Synthesis and pharmacological activity of triazole derivatives inhibiting eosinophilia","volume":"39","author":"Naito","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108899_bb0195","first-page":"36","article-title":"Studies with 2-arylhydrazono-3-oxopropanals: routes for the synthesis of pyridazine-3, 4-dicarboxylate and 3, 5-diaroylpyrazoles","volume":"17","author":"Al-Shiekh","year":"2008","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2025.108899_bb0200","series-title":"Synthesis, photophysical and redox properties of the 2, 5, 7-tri (het) aryl-[1, 2, 4] triazolo [1, 5-a] pyrimidines","author":"Rasputin","year":"2020"},{"issue":"15","key":"10.1016\/j.bioorg.2025.108899_bb0205","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1158\/0008-5472.CAN-23-3031","article-title":"HTS384 NCI60: the next phase of the NCI60 screen","volume":"84","author":"Kunkel","year":"2024","journal-title":"Cancer Res."},{"issue":"6_Supplement","key":"10.1016\/j.bioorg.2025.108899_bb0210","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1158\/1538-7445.AM2024-3090","article-title":"Development and performance of the National Cancer Institute\u2019s HTS384 NCI60 screen: A modernized platform to support drug discovery and development by the worldwide cancer research community","volume":"84","author":"Coussens","year":"2024","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.108899_bb0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108899_bb0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrd4504","article-title":"The history and future of targeting cyclin-dependent kinases in cancer therapy","volume":"14","author":"Asghar","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108899_bb0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.apsb.2020.05.004","article-title":"Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers","volume":"11","author":"Jiang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108899_bb0230","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/adt.2009.0222","article-title":"ADP-Glo: A bioluminescent and homogeneous ADP monitoring assay for kinases","volume":"7","author":"Zegzouti","year":"2009","journal-title":"Assay Drug Dev. Technol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0235","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1080\/14756366.2022.2104841","article-title":"Discovery of novel thiazolyl-pyrazolines as dual EGFR and VEGFR-2 inhibitors endowed with in vitro antitumor activity towards non-small lung cancer","volume":"37","author":"Abdelsalam","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108899_bb0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","article-title":"A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V","volume":"184","author":"Vermes","year":"1995","journal-title":"J. Immunol. Methods"},{"issue":"9","key":"10.1016\/j.bioorg.2025.108899_bb0250","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1021\/acs.jcim.5b00142","article-title":"POSIT: flexible shape-guided docking for pose prediction","volume":"55","author":"Kelley","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108899_bb0255","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/ci500588j","article-title":"DataWarrior: an open-source program for chemistry aware data visualization and analysis","volume":"55","author":"Sander","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108899_bb0260","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1093\/bioinformatics\/btaa018","article-title":"LigRMSD: A web server for automatic structure matching and RMSD calculations among identical and similar compounds in protein-ligand docking","volume":"36","author":"Vel\u00e1zquez-Libera","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bioorg.2025.108899_bb0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"High performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"43","key":"10.1016\/j.bioorg.2025.108899_bb0270","first-page":"9954","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"Chem. Eur. J."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108899_bb0275","doi-asserted-by":"crossref","DOI":"10.1063\/1.2408420","article-title":"Canonical sampling through velocity rescaling","volume":"126","author":"Bussi","year":"2007","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108899_bb0280","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108899_bb0285","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: A new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J. Appl. Phys."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108899_bb0290","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N\u00b7log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108899_bb0295","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","article-title":"LINCS: A linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108899_bb0300","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108899_bb0305","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.bioorg.2025.108899_bb0310","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general Amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2025.108899_bb0315","series-title":"Proceedings of the 15th Python in Science Conference","doi-asserted-by":"crossref","first-page":"98","DOI":"10.25080\/Majora-629e541a-00e","article-title":"MDAnalysis: A Python package for the rapid analysis of molecular dynamics simulations","author":"Gowers","year":"2016"},{"issue":"10","key":"10.1016\/j.bioorg.2025.108899_bb0320","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: A toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108899_bb0325","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: A 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comp. Sci. & Eng."},{"key":"10.1016\/j.bioorg.2025.108899_bb0330","first-page":"123","article-title":"StreaMD: the toolkit for high-throughput molecular dynamics simulations","volume":"16","author":"Ivanova","year":"2024","journal-title":"J. Chemother."},{"key":"10.1016\/j.bioorg.2025.108899_bb0335","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"W1","key":"10.1016\/j.bioorg.2025.108899_bb0340","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825007795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T20:25:25Z","timestamp":1760559925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825007795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":68,"alternative-id":["S0045206825007795"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108899","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of triazolo[1,5-a]pyrimidine derivatives as new antiproliferative agents with multikinase inhibitory activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108899","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108899"}}